nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP2C8—Mometasone—systemic scleroderma	0.084	0.136	CbGbCtD
Amitriptyline—ALB—Captopril—systemic scleroderma	0.0549	0.0891	CbGbCtD
Amitriptyline—CYP1A2—Pentoxifylline—systemic scleroderma	0.0439	0.0712	CbGbCtD
Amitriptyline—ALB—Mycophenolate mofetil—systemic scleroderma	0.0433	0.0701	CbGbCtD
Amitriptyline—CYP1A2—Leflunomide—systemic scleroderma	0.0419	0.0679	CbGbCtD
Amitriptyline—ABCB1—Lisinopril—systemic scleroderma	0.0384	0.0623	CbGbCtD
Amitriptyline—CYP2C9—Leflunomide—systemic scleroderma	0.0377	0.0612	CbGbCtD
Amitriptyline—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0348	0.0564	CbGbCtD
Amitriptyline—ALB—Prednisone—systemic scleroderma	0.0346	0.0561	CbGbCtD
Amitriptyline—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0334	0.0542	CbGbCtD
Amitriptyline—ABCB1—Captopril—systemic scleroderma	0.0287	0.0466	CbGbCtD
Amitriptyline—CYP2D6—Captopril—systemic scleroderma	0.0271	0.0439	CbGbCtD
Amitriptyline—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0226	0.0367	CbGbCtD
Amitriptyline—CYP2C19—Prednisone—systemic scleroderma	0.0224	0.0364	CbGbCtD
Amitriptyline—ABCB1—Prednisone—systemic scleroderma	0.0181	0.0293	CbGbCtD
Amitriptyline—ALB—Methotrexate—systemic scleroderma	0.0173	0.0281	CbGbCtD
Amitriptyline—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0136	0.022	CbGbCtD
Amitriptyline—CYP2C9—cardial valve—systemic scleroderma	0.0117	0.116	CbGeAlD
Amitriptyline—CYP3A4—Prednisone—systemic scleroderma	0.0108	0.0176	CbGbCtD
Amitriptyline—ABCB1—Methotrexate—systemic scleroderma	0.00908	0.0147	CbGbCtD
Amitriptyline—HTR7—myenteric nerve plexus—systemic scleroderma	0.00887	0.0875	CbGeAlD
Amitriptyline—HTR7—pulmonary artery—systemic scleroderma	0.00628	0.062	CbGeAlD
Amitriptyline—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00553	0.0546	CbGeAlD
Amitriptyline—NTRK2—connective tissue—systemic scleroderma	0.00408	0.0402	CbGeAlD
Amitriptyline—HTR2A—pulmonary artery—systemic scleroderma	0.00392	0.0386	CbGeAlD
Amitriptyline—HTR1B—artery—systemic scleroderma	0.00302	0.0298	CbGeAlD
Amitriptyline—HTR1D—artery—systemic scleroderma	0.00292	0.0288	CbGeAlD
Amitriptyline—NTRK2—lung—systemic scleroderma	0.00246	0.0243	CbGeAlD
Amitriptyline—HTR1B—blood vessel—systemic scleroderma	0.00235	0.0232	CbGeAlD
Amitriptyline—HTR7—artery—systemic scleroderma	0.00233	0.023	CbGeAlD
Amitriptyline—HTR1D—blood vessel—systemic scleroderma	0.00228	0.0225	CbGeAlD
Amitriptyline—HTR7—endothelium—systemic scleroderma	0.00197	0.0194	CbGeAlD
Amitriptyline—KCNQ3—lung—systemic scleroderma	0.00186	0.0184	CbGeAlD
Amitriptyline—HTR7—blood vessel—systemic scleroderma	0.00181	0.0179	CbGeAlD
Amitriptyline—HRH2—skin of body—systemic scleroderma	0.00165	0.0163	CbGeAlD
Amitriptyline—KCNA1—tendon—systemic scleroderma	0.00162	0.016	CbGeAlD
Amitriptyline—CHRM5—skin of body—systemic scleroderma	0.00158	0.0156	CbGeAlD
Amitriptyline—HTR2A—artery—systemic scleroderma	0.00145	0.0143	CbGeAlD
Amitriptyline—KCND3—lung—systemic scleroderma	0.00142	0.014	CbGeAlD
Amitriptyline—HRH2—digestive system—systemic scleroderma	0.00132	0.013	CbGeAlD
Amitriptyline—HTR2A—endothelium—systemic scleroderma	0.00123	0.0121	CbGeAlD
Amitriptyline—HTR1D—connective tissue—systemic scleroderma	0.00117	0.0115	CbGeAlD
Amitriptyline—HTR2A—blood vessel—systemic scleroderma	0.00113	0.0112	CbGeAlD
Amitriptyline—HRH2—lung—systemic scleroderma	0.0011	0.0109	CbGeAlD
Amitriptyline—SIGMAR1—smooth muscle tissue—systemic scleroderma	0.000996	0.00982	CbGeAlD
Amitriptyline—HTR7—connective tissue—systemic scleroderma	0.00093	0.00918	CbGeAlD
Amitriptyline—CHRM3—smooth muscle tissue—systemic scleroderma	0.000894	0.00882	CbGeAlD
Amitriptyline—HTR7—smooth muscle tissue—systemic scleroderma	0.000851	0.00839	CbGeAlD
Amitriptyline—SLC6A4—digestive system—systemic scleroderma	0.000792	0.00781	CbGeAlD
Amitriptyline—ORM1—lung—systemic scleroderma	0.000776	0.00766	CbGeAlD
Amitriptyline—SIGMAR1—tendon—systemic scleroderma	0.000748	0.00738	CbGeAlD
Amitriptyline—ABCB1—blood vessel—systemic scleroderma	0.000741	0.00731	CbGeAlD
Amitriptyline—CHRM3—digestive system—systemic scleroderma	0.000706	0.00696	CbGeAlD
Amitriptyline—HRH1—connective tissue—systemic scleroderma	0.000694	0.00685	CbGeAlD
Amitriptyline—ADRA2A—connective tissue—systemic scleroderma	0.000682	0.00673	CbGeAlD
Amitriptyline—HTR7—digestive system—systemic scleroderma	0.000672	0.00663	CbGeAlD
Amitriptyline—SLC6A4—lung—systemic scleroderma	0.000661	0.00652	CbGeAlD
Amitriptyline—CHRM1—lung—systemic scleroderma	0.000659	0.0065	CbGeAlD
Amitriptyline—SIGMAR1—lung—systemic scleroderma	0.000657	0.00648	CbGeAlD
Amitriptyline—CYP2C19—digestive system—systemic scleroderma	0.000656	0.00647	CbGeAlD
Amitriptyline—CYP2B6—skin of body—systemic scleroderma	0.000642	0.00633	CbGeAlD
Amitriptyline—HTR7—tendon—systemic scleroderma	0.000639	0.00631	CbGeAlD
Amitriptyline—HRH1—smooth muscle tissue—systemic scleroderma	0.000635	0.00627	CbGeAlD
Amitriptyline—SLC6A2—lung—systemic scleroderma	0.000582	0.00574	CbGeAlD
Amitriptyline—HTR2A—connective tissue—systemic scleroderma	0.00058	0.00572	CbGeAlD
Amitriptyline—HTR7—lung—systemic scleroderma	0.000561	0.00553	CbGeAlD
Amitriptyline—CYP1A2—digestive system—systemic scleroderma	0.000536	0.00529	CbGeAlD
Amitriptyline—HTR2A—smooth muscle tissue—systemic scleroderma	0.00053	0.00523	CbGeAlD
Amitriptyline—DRD2—lung—systemic scleroderma	0.00053	0.00523	CbGeAlD
Amitriptyline—CYP3A5—digestive system—systemic scleroderma	0.000517	0.0051	CbGeAlD
Amitriptyline—CYP2B6—digestive system—systemic scleroderma	0.000513	0.00507	CbGeAlD
Amitriptyline—CYP2C9—digestive system—systemic scleroderma	0.000508	0.00502	CbGeAlD
Amitriptyline—HRH1—digestive system—systemic scleroderma	0.000501	0.00495	CbGeAlD
Amitriptyline—CYP2E1—digestive system—systemic scleroderma	0.000482	0.00476	CbGeAlD
Amitriptyline—HRH1—tendon—systemic scleroderma	0.000477	0.00471	CbGeAlD
Amitriptyline—ADRA2A—tendon—systemic scleroderma	0.000469	0.00463	CbGeAlD
Amitriptyline—CYP2E1—tendon—systemic scleroderma	0.000459	0.00453	CbGeAlD
Amitriptyline—Feeling abnormal—Captopril—systemic scleroderma	0.000454	0.00169	CcSEcCtD
Amitriptyline—Vision blurred—Lisinopril—systemic scleroderma	0.000451	0.00168	CcSEcCtD
Amitriptyline—Anxiety—Mycophenolic acid—systemic scleroderma	0.00045	0.00167	CcSEcCtD
Amitriptyline—Asthenia—Mometasone—systemic scleroderma	0.00045	0.00167	CcSEcCtD
Amitriptyline—Irritability—Prednisone—systemic scleroderma	0.00045	0.00167	CcSEcCtD
Amitriptyline—Hypotension—Azathioprine—systemic scleroderma	0.000449	0.00167	CcSEcCtD
Amitriptyline—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000449	0.00167	CcSEcCtD
Amitriptyline—Tremor—Lisinopril—systemic scleroderma	0.000448	0.00167	CcSEcCtD
Amitriptyline—CYP1A2—lung—systemic scleroderma	0.000447	0.00441	CbGeAlD
Amitriptyline—Discomfort—Mycophenolic acid—systemic scleroderma	0.000447	0.00166	CcSEcCtD
Amitriptyline—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000445	0.00165	CcSEcCtD
Amitriptyline—Pruritus—Mometasone—systemic scleroderma	0.000444	0.00165	CcSEcCtD
Amitriptyline—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000444	0.00165	CcSEcCtD
Amitriptyline—Tachycardia—Leflunomide—systemic scleroderma	0.000443	0.00165	CcSEcCtD
Amitriptyline—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000442	0.00164	CcSEcCtD
Amitriptyline—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000439	0.00163	CcSEcCtD
Amitriptyline—Hepatic failure—Methotrexate—systemic scleroderma	0.000439	0.00163	CcSEcCtD
Amitriptyline—Confusional state—Mycophenolic acid—systemic scleroderma	0.000437	0.00162	CcSEcCtD
Amitriptyline—Body temperature increased—Captopril—systemic scleroderma	0.000436	0.00162	CcSEcCtD
Amitriptyline—Oedema—Mycophenolic acid—systemic scleroderma	0.000433	0.00161	CcSEcCtD
Amitriptyline—Anorexia—Leflunomide—systemic scleroderma	0.000433	0.00161	CcSEcCtD
Amitriptyline—Nausea—Pentoxifylline—systemic scleroderma	0.000432	0.00161	CcSEcCtD
Amitriptyline—CYP3A5—lung—systemic scleroderma	0.000432	0.00426	CbGeAlD
Amitriptyline—Malaise—Lisinopril—systemic scleroderma	0.000431	0.0016	CcSEcCtD
Amitriptyline—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00043	0.0016	CcSEcCtD
Amitriptyline—Diarrhoea—Mometasone—systemic scleroderma	0.000429	0.0016	CcSEcCtD
Amitriptyline—CYP2B6—lung—systemic scleroderma	0.000429	0.00423	CbGeAlD
Amitriptyline—Syncope—Lisinopril—systemic scleroderma	0.000429	0.00159	CcSEcCtD
Amitriptyline—Leukopenia—Lisinopril—systemic scleroderma	0.000428	0.00159	CcSEcCtD
Amitriptyline—Shock—Mycophenolic acid—systemic scleroderma	0.000426	0.00158	CcSEcCtD
Amitriptyline—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.000425	0.00158	CcSEcCtD
Amitriptyline—Hypotension—Leflunomide—systemic scleroderma	0.000424	0.00158	CcSEcCtD
Amitriptyline—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000424	0.00158	CcSEcCtD
Amitriptyline—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000423	0.00157	CcSEcCtD
Amitriptyline—Palpitations—Lisinopril—systemic scleroderma	0.000423	0.00157	CcSEcCtD
Amitriptyline—Loss of consciousness—Lisinopril—systemic scleroderma	0.00042	0.00156	CcSEcCtD
Amitriptyline—HTR2A—digestive system—systemic scleroderma	0.000419	0.00413	CbGeAlD
Amitriptyline—HRH1—lung—systemic scleroderma	0.000419	0.00413	CbGeAlD
Amitriptyline—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000419	0.00156	CcSEcCtD
Amitriptyline—Anorexia—Mycophenolic acid—systemic scleroderma	0.000413	0.00154	CcSEcCtD
Amitriptyline—ADRA2A—lung—systemic scleroderma	0.000411	0.00406	CbGeAlD
Amitriptyline—Insomnia—Leflunomide—systemic scleroderma	0.000411	0.00153	CcSEcCtD
Amitriptyline—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00041	0.00153	CcSEcCtD
Amitriptyline—Paraesthesia—Leflunomide—systemic scleroderma	0.000408	0.00152	CcSEcCtD
Amitriptyline—Anxiety—Lisinopril—systemic scleroderma	0.000406	0.00151	CcSEcCtD
Amitriptyline—Hypotension—Mycophenolic acid—systemic scleroderma	0.000405	0.00151	CcSEcCtD
Amitriptyline—CYP2E1—lung—systemic scleroderma	0.000402	0.00397	CbGeAlD
Amitriptyline—Discomfort—Lisinopril—systemic scleroderma	0.000402	0.0015	CcSEcCtD
Amitriptyline—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000402	0.0015	CcSEcCtD
Amitriptyline—Dyspepsia—Leflunomide—systemic scleroderma	0.0004	0.00149	CcSEcCtD
Amitriptyline—Vomiting—Mometasone—systemic scleroderma	0.000399	0.00148	CcSEcCtD
Amitriptyline—HTR2A—tendon—systemic scleroderma	0.000399	0.00393	CbGeAlD
Amitriptyline—Dry mouth—Lisinopril—systemic scleroderma	0.000398	0.00148	CcSEcCtD
Amitriptyline—Sweating increased—Prednisone—systemic scleroderma	0.000397	0.00148	CcSEcCtD
Amitriptyline—Feeling abnormal—Azathioprine—systemic scleroderma	0.000396	0.00147	CcSEcCtD
Amitriptyline—Rash—Mometasone—systemic scleroderma	0.000396	0.00147	CcSEcCtD
Amitriptyline—Asthenia—Captopril—systemic scleroderma	0.000395	0.00147	CcSEcCtD
Amitriptyline—Dermatitis—Mometasone—systemic scleroderma	0.000395	0.00147	CcSEcCtD
Amitriptyline—Decreased appetite—Leflunomide—systemic scleroderma	0.000395	0.00147	CcSEcCtD
Amitriptyline—Osteoarthritis—Methotrexate—systemic scleroderma	0.000394	0.00147	CcSEcCtD
Amitriptyline—Confusional state—Lisinopril—systemic scleroderma	0.000393	0.00146	CcSEcCtD
Amitriptyline—Headache—Mometasone—systemic scleroderma	0.000393	0.00146	CcSEcCtD
Amitriptyline—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000392	0.00146	CcSEcCtD
Amitriptyline—Insomnia—Mycophenolic acid—systemic scleroderma	0.000392	0.00146	CcSEcCtD
Amitriptyline—Fatigue—Leflunomide—systemic scleroderma	0.000392	0.00146	CcSEcCtD
Amitriptyline—Oedema—Lisinopril—systemic scleroderma	0.00039	0.00145	CcSEcCtD
Amitriptyline—Pruritus—Captopril—systemic scleroderma	0.00039	0.00145	CcSEcCtD
Amitriptyline—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000389	0.00145	CcSEcCtD
Amitriptyline—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00145	CcSEcCtD
Amitriptyline—Constipation—Leflunomide—systemic scleroderma	0.000388	0.00144	CcSEcCtD
Amitriptyline—CYP3A4—digestive system—systemic scleroderma	0.000388	0.00383	CbGeAlD
Amitriptyline—Somnolence—Mycophenolic acid—systemic scleroderma	0.000385	0.00143	CcSEcCtD
Amitriptyline—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000385	0.00143	CcSEcCtD
Amitriptyline—Shock—Lisinopril—systemic scleroderma	0.000384	0.00143	CcSEcCtD
Amitriptyline—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000382	0.00142	CcSEcCtD
Amitriptyline—CYP2D6—digestive system—systemic scleroderma	0.000382	0.00377	CbGeAlD
Amitriptyline—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000381	0.00142	CcSEcCtD
Amitriptyline—Tachycardia—Lisinopril—systemic scleroderma	0.000381	0.00142	CcSEcCtD
Amitriptyline—Body temperature increased—Azathioprine—systemic scleroderma	0.00038	0.00141	CcSEcCtD
Amitriptyline—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000378	0.0014	CcSEcCtD
Amitriptyline—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000377	0.0014	CcSEcCtD
Amitriptyline—Diarrhoea—Captopril—systemic scleroderma	0.000377	0.0014	CcSEcCtD
Amitriptyline—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000377	0.0014	CcSEcCtD
Amitriptyline—Irritability—Methotrexate—systemic scleroderma	0.000376	0.0014	CcSEcCtD
Amitriptyline—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000376	0.0014	CcSEcCtD
Amitriptyline—Erectile dysfunction—Prednisone—systemic scleroderma	0.000375	0.0014	CcSEcCtD
Amitriptyline—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00139	CcSEcCtD
Amitriptyline—Feeling abnormal—Leflunomide—systemic scleroderma	0.000374	0.00139	CcSEcCtD
Amitriptyline—Fatigue—Mycophenolic acid—systemic scleroderma	0.000374	0.00139	CcSEcCtD
Amitriptyline—Nausea—Mometasone—systemic scleroderma	0.000373	0.00139	CcSEcCtD
Amitriptyline—Anorexia—Lisinopril—systemic scleroderma	0.000372	0.00138	CcSEcCtD
Amitriptyline—Weight increased—Prednisone—systemic scleroderma	0.000371	0.00138	CcSEcCtD
Amitriptyline—Ataxia—Methotrexate—systemic scleroderma	0.000371	0.00138	CcSEcCtD
Amitriptyline—Constipation—Mycophenolic acid—systemic scleroderma	0.00037	0.00138	CcSEcCtD
Amitriptyline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00037	0.00138	CcSEcCtD
Amitriptyline—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000368	0.00137	CcSEcCtD
Amitriptyline—Hypotension—Lisinopril—systemic scleroderma	0.000365	0.00136	CcSEcCtD
Amitriptyline—Dizziness—Captopril—systemic scleroderma	0.000364	0.00135	CcSEcCtD
Amitriptyline—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000363	0.00135	CcSEcCtD
Amitriptyline—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00134	CcSEcCtD
Amitriptyline—Urticaria—Leflunomide—systemic scleroderma	0.000361	0.00134	CcSEcCtD
Amitriptyline—Body temperature increased—Leflunomide—systemic scleroderma	0.000359	0.00133	CcSEcCtD
Amitriptyline—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000358	0.00133	CcSEcCtD
Amitriptyline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000357	0.00133	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000356	0.00132	CcSEcCtD
Amitriptyline—Myocardial infarction—Prednisone—systemic scleroderma	0.000356	0.00132	CcSEcCtD
Amitriptyline—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000355	0.00132	CcSEcCtD
Amitriptyline—Insomnia—Lisinopril—systemic scleroderma	0.000353	0.00131	CcSEcCtD
Amitriptyline—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000352	0.00131	CcSEcCtD
Amitriptyline—Paraesthesia—Lisinopril—systemic scleroderma	0.00035	0.0013	CcSEcCtD
Amitriptyline—Vomiting—Captopril—systemic scleroderma	0.00035	0.0013	CcSEcCtD
Amitriptyline—HTR2A—lung—systemic scleroderma	0.00035	0.00345	CbGeAlD
Amitriptyline—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000349	0.0013	CcSEcCtD
Amitriptyline—Rash—Captopril—systemic scleroderma	0.000347	0.00129	CcSEcCtD
Amitriptyline—Dermatitis—Captopril—systemic scleroderma	0.000347	0.00129	CcSEcCtD
Amitriptyline—Somnolence—Lisinopril—systemic scleroderma	0.000347	0.00129	CcSEcCtD
Amitriptyline—Headache—Captopril—systemic scleroderma	0.000345	0.00128	CcSEcCtD
Amitriptyline—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000345	0.00128	CcSEcCtD
Amitriptyline—Dyspepsia—Lisinopril—systemic scleroderma	0.000343	0.00128	CcSEcCtD
Amitriptyline—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000342	0.00127	CcSEcCtD
Amitriptyline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00127	CcSEcCtD
Amitriptyline—Decreased appetite—Lisinopril—systemic scleroderma	0.000339	0.00126	CcSEcCtD
Amitriptyline—Eosinophilia—Methotrexate—systemic scleroderma	0.000337	0.00125	CcSEcCtD
Amitriptyline—Fatigue—Lisinopril—systemic scleroderma	0.000336	0.00125	CcSEcCtD
Amitriptyline—Shock—Mycophenolate mofetil—systemic scleroderma	0.000336	0.00125	CcSEcCtD
Amitriptyline—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000335	0.00124	CcSEcCtD
Amitriptyline—Constipation—Lisinopril—systemic scleroderma	0.000334	0.00124	CcSEcCtD
Amitriptyline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000334	0.00124	CcSEcCtD
Amitriptyline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000331	0.00123	CcSEcCtD
Amitriptyline—Diarrhoea—Azathioprine—systemic scleroderma	0.000329	0.00122	CcSEcCtD
Amitriptyline—Nausea—Captopril—systemic scleroderma	0.000327	0.00122	CcSEcCtD
Amitriptyline—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000326	0.00121	CcSEcCtD
Amitriptyline—Asthenia—Leflunomide—systemic scleroderma	0.000326	0.00121	CcSEcCtD
Amitriptyline—Hallucination—Prednisone—systemic scleroderma	0.000325	0.00121	CcSEcCtD
Amitriptyline—Pancytopenia—Methotrexate—systemic scleroderma	0.000323	0.0012	CcSEcCtD
Amitriptyline—Feeling abnormal—Lisinopril—systemic scleroderma	0.000322	0.0012	CcSEcCtD
Amitriptyline—Pruritus—Leflunomide—systemic scleroderma	0.000321	0.00119	CcSEcCtD
Amitriptyline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000319	0.00119	CcSEcCtD
Amitriptyline—Dizziness—Azathioprine—systemic scleroderma	0.000318	0.00118	CcSEcCtD
Amitriptyline—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000314	0.00117	CcSEcCtD
Amitriptyline—Asthenia—Mycophenolic acid—systemic scleroderma	0.000311	0.00116	CcSEcCtD
Amitriptyline—Diarrhoea—Leflunomide—systemic scleroderma	0.000311	0.00116	CcSEcCtD
Amitriptyline—Urticaria—Lisinopril—systemic scleroderma	0.00031	0.00115	CcSEcCtD
Amitriptyline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00115	CcSEcCtD
Amitriptyline—Body temperature increased—Lisinopril—systemic scleroderma	0.000308	0.00115	CcSEcCtD
Amitriptyline—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000307	0.00114	CcSEcCtD
Amitriptyline—Pruritus—Mycophenolic acid—systemic scleroderma	0.000307	0.00114	CcSEcCtD
Amitriptyline—Vomiting—Azathioprine—systemic scleroderma	0.000306	0.00114	CcSEcCtD
Amitriptyline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00113	CcSEcCtD
Amitriptyline—Drowsiness—Methotrexate—systemic scleroderma	0.000304	0.00113	CcSEcCtD
Amitriptyline—Rash—Azathioprine—systemic scleroderma	0.000303	0.00113	CcSEcCtD
Amitriptyline—Dermatitis—Azathioprine—systemic scleroderma	0.000303	0.00113	CcSEcCtD
Amitriptyline—Headache—Azathioprine—systemic scleroderma	0.000301	0.00112	CcSEcCtD
Amitriptyline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000301	0.00112	CcSEcCtD
Amitriptyline—Dizziness—Leflunomide—systemic scleroderma	0.0003	0.00112	CcSEcCtD
Amitriptyline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00111	CcSEcCtD
Amitriptyline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000296	0.0011	CcSEcCtD
Amitriptyline—Stomatitis—Methotrexate—systemic scleroderma	0.000296	0.0011	CcSEcCtD
Amitriptyline—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000292	0.00109	CcSEcCtD
Amitriptyline—Arrhythmia—Prednisone—systemic scleroderma	0.000291	0.00108	CcSEcCtD
Amitriptyline—Vomiting—Leflunomide—systemic scleroderma	0.000289	0.00107	CcSEcCtD
Amitriptyline—Alopecia—Prednisone—systemic scleroderma	0.000288	0.00107	CcSEcCtD
Amitriptyline—Dizziness—Mycophenolic acid—systemic scleroderma	0.000286	0.00107	CcSEcCtD
Amitriptyline—Rash—Leflunomide—systemic scleroderma	0.000286	0.00106	CcSEcCtD
Amitriptyline—Dermatitis—Leflunomide—systemic scleroderma	0.000286	0.00106	CcSEcCtD
Amitriptyline—Nausea—Azathioprine—systemic scleroderma	0.000286	0.00106	CcSEcCtD
Amitriptyline—Headache—Leflunomide—systemic scleroderma	0.000284	0.00106	CcSEcCtD
Amitriptyline—Agranulocytosis—Methotrexate—systemic scleroderma	0.000283	0.00105	CcSEcCtD
Amitriptyline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000282	0.00105	CcSEcCtD
Amitriptyline—Asthenia—Lisinopril—systemic scleroderma	0.00028	0.00104	CcSEcCtD
Amitriptyline—Pruritus—Lisinopril—systemic scleroderma	0.000276	0.00103	CcSEcCtD
Amitriptyline—Vomiting—Mycophenolic acid—systemic scleroderma	0.000275	0.00102	CcSEcCtD
Amitriptyline—ABCB1—digestive system—systemic scleroderma	0.000274	0.00271	CbGeAlD
Amitriptyline—Rash—Mycophenolic acid—systemic scleroderma	0.000273	0.00102	CcSEcCtD
Amitriptyline—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000273	0.00101	CcSEcCtD
Amitriptyline—Hepatitis—Methotrexate—systemic scleroderma	0.000273	0.00101	CcSEcCtD
Amitriptyline—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000272	0.00101	CcSEcCtD
Amitriptyline—Headache—Mycophenolic acid—systemic scleroderma	0.000271	0.00101	CcSEcCtD
Amitriptyline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00027	0.001	CcSEcCtD
Amitriptyline—Nausea—Leflunomide—systemic scleroderma	0.00027	0.001	CcSEcCtD
Amitriptyline—Vision blurred—Prednisone—systemic scleroderma	0.000268	0.000995	CcSEcCtD
Amitriptyline—Diarrhoea—Lisinopril—systemic scleroderma	0.000267	0.000993	CcSEcCtD
Amitriptyline—Ill-defined disorder—Prednisone—systemic scleroderma	0.000263	0.00098	CcSEcCtD
Amitriptyline—Agitation—Prednisone—systemic scleroderma	0.000261	0.00097	CcSEcCtD
Amitriptyline—Dizziness—Lisinopril—systemic scleroderma	0.000258	0.000959	CcSEcCtD
Amitriptyline—Nausea—Mycophenolic acid—systemic scleroderma	0.000257	0.000957	CcSEcCtD
Amitriptyline—Malaise—Prednisone—systemic scleroderma	0.000256	0.000952	CcSEcCtD
Amitriptyline—Syncope—Prednisone—systemic scleroderma	0.000255	0.000947	CcSEcCtD
Amitriptyline—Tinnitus—Methotrexate—systemic scleroderma	0.000254	0.000945	CcSEcCtD
Amitriptyline—Loss of consciousness—Prednisone—systemic scleroderma	0.00025	0.000928	CcSEcCtD
Amitriptyline—Vomiting—Lisinopril—systemic scleroderma	0.000248	0.000922	CcSEcCtD
Amitriptyline—Rash—Lisinopril—systemic scleroderma	0.000246	0.000915	CcSEcCtD
Amitriptyline—Convulsion—Prednisone—systemic scleroderma	0.000246	0.000915	CcSEcCtD
Amitriptyline—Dermatitis—Lisinopril—systemic scleroderma	0.000246	0.000914	CcSEcCtD
Amitriptyline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000245	0.000912	CcSEcCtD
Amitriptyline—Hypertension—Prednisone—systemic scleroderma	0.000245	0.000912	CcSEcCtD
Amitriptyline—Headache—Lisinopril—systemic scleroderma	0.000244	0.000909	CcSEcCtD
Amitriptyline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000899	CcSEcCtD
Amitriptyline—Anxiety—Prednisone—systemic scleroderma	0.000241	0.000896	CcSEcCtD
Amitriptyline—Alopecia—Methotrexate—systemic scleroderma	0.000241	0.000896	CcSEcCtD
Amitriptyline—Discomfort—Prednisone—systemic scleroderma	0.000239	0.000888	CcSEcCtD
Amitriptyline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000234	0.00087	CcSEcCtD
Amitriptyline—Dysgeusia—Methotrexate—systemic scleroderma	0.000232	0.000864	CcSEcCtD
Amitriptyline—Nausea—Lisinopril—systemic scleroderma	0.000232	0.000862	CcSEcCtD
Amitriptyline—Oedema—Prednisone—systemic scleroderma	0.000232	0.000862	CcSEcCtD
Amitriptyline—ABCB1—lung—systemic scleroderma	0.000229	0.00226	CbGeAlD
Amitriptyline—Shock—Prednisone—systemic scleroderma	0.000228	0.000848	CcSEcCtD
Amitriptyline—Tachycardia—Prednisone—systemic scleroderma	0.000226	0.000841	CcSEcCtD
Amitriptyline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000841	CcSEcCtD
Amitriptyline—Hyperhidrosis—Prednisone—systemic scleroderma	0.000224	0.000833	CcSEcCtD
Amitriptyline—Vision blurred—Methotrexate—systemic scleroderma	0.000224	0.000832	CcSEcCtD
Amitriptyline—Anorexia—Prednisone—systemic scleroderma	0.000221	0.000821	CcSEcCtD
Amitriptyline—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00022	0.000819	CcSEcCtD
Amitriptyline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000808	CcSEcCtD
Amitriptyline—Rash—Mycophenolate mofetil—systemic scleroderma	0.000216	0.000801	CcSEcCtD
Amitriptyline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000801	CcSEcCtD
Amitriptyline—Headache—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000796	CcSEcCtD
Amitriptyline—Malaise—Methotrexate—systemic scleroderma	0.000214	0.000796	CcSEcCtD
Amitriptyline—Leukopenia—Methotrexate—systemic scleroderma	0.000212	0.00079	CcSEcCtD
Amitriptyline—Insomnia—Prednisone—systemic scleroderma	0.00021	0.000779	CcSEcCtD
Amitriptyline—Paraesthesia—Prednisone—systemic scleroderma	0.000208	0.000774	CcSEcCtD
Amitriptyline—Convulsion—Methotrexate—systemic scleroderma	0.000206	0.000764	CcSEcCtD
Amitriptyline—Dyspepsia—Prednisone—systemic scleroderma	0.000204	0.000758	CcSEcCtD
Amitriptyline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000755	CcSEcCtD
Amitriptyline—Decreased appetite—Prednisone—systemic scleroderma	0.000201	0.000749	CcSEcCtD
Amitriptyline—Fatigue—Prednisone—systemic scleroderma	0.0002	0.000743	CcSEcCtD
Amitriptyline—Discomfort—Methotrexate—systemic scleroderma	0.0002	0.000742	CcSEcCtD
Amitriptyline—Constipation—Prednisone—systemic scleroderma	0.000198	0.000737	CcSEcCtD
Amitriptyline—Confusional state—Methotrexate—systemic scleroderma	0.000195	0.000726	CcSEcCtD
Amitriptyline—Feeling abnormal—Prednisone—systemic scleroderma	0.000191	0.00071	CcSEcCtD
Amitriptyline—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00019	0.000705	CcSEcCtD
Amitriptyline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000187	0.000696	CcSEcCtD
Amitriptyline—Anorexia—Methotrexate—systemic scleroderma	0.000185	0.000686	CcSEcCtD
Amitriptyline—Urticaria—Prednisone—systemic scleroderma	0.000184	0.000685	CcSEcCtD
Amitriptyline—Body temperature increased—Prednisone—systemic scleroderma	0.000183	0.000681	CcSEcCtD
Amitriptyline—Hypotension—Methotrexate—systemic scleroderma	0.000181	0.000673	CcSEcCtD
Amitriptyline—Insomnia—Methotrexate—systemic scleroderma	0.000175	0.000651	CcSEcCtD
Amitriptyline—Paraesthesia—Methotrexate—systemic scleroderma	0.000174	0.000647	CcSEcCtD
Amitriptyline—Somnolence—Methotrexate—systemic scleroderma	0.000172	0.00064	CcSEcCtD
Amitriptyline—Dyspepsia—Methotrexate—systemic scleroderma	0.00017	0.000634	CcSEcCtD
Amitriptyline—Decreased appetite—Methotrexate—systemic scleroderma	0.000168	0.000626	CcSEcCtD
Amitriptyline—Fatigue—Methotrexate—systemic scleroderma	0.000167	0.000621	CcSEcCtD
Amitriptyline—Asthenia—Prednisone—systemic scleroderma	0.000166	0.000618	CcSEcCtD
Amitriptyline—Pruritus—Prednisone—systemic scleroderma	0.000164	0.00061	CcSEcCtD
Amitriptyline—Feeling abnormal—Methotrexate—systemic scleroderma	0.00016	0.000593	CcSEcCtD
Amitriptyline—Diarrhoea—Prednisone—systemic scleroderma	0.000159	0.00059	CcSEcCtD
Amitriptyline—Urticaria—Methotrexate—systemic scleroderma	0.000154	0.000572	CcSEcCtD
Amitriptyline—Dizziness—Prednisone—systemic scleroderma	0.000153	0.00057	CcSEcCtD
Amitriptyline—Body temperature increased—Methotrexate—systemic scleroderma	0.000153	0.000569	CcSEcCtD
Amitriptyline—Vomiting—Prednisone—systemic scleroderma	0.000147	0.000548	CcSEcCtD
Amitriptyline—Rash—Prednisone—systemic scleroderma	0.000146	0.000543	CcSEcCtD
Amitriptyline—Dermatitis—Prednisone—systemic scleroderma	0.000146	0.000543	CcSEcCtD
Amitriptyline—Headache—Prednisone—systemic scleroderma	0.000145	0.00054	CcSEcCtD
Amitriptyline—Asthenia—Methotrexate—systemic scleroderma	0.000139	0.000517	CcSEcCtD
Amitriptyline—Nausea—Prednisone—systemic scleroderma	0.000138	0.000512	CcSEcCtD
Amitriptyline—Pruritus—Methotrexate—systemic scleroderma	0.000137	0.000509	CcSEcCtD
Amitriptyline—Diarrhoea—Methotrexate—systemic scleroderma	0.000133	0.000493	CcSEcCtD
Amitriptyline—Dizziness—Methotrexate—systemic scleroderma	0.000128	0.000476	CcSEcCtD
Amitriptyline—Vomiting—Methotrexate—systemic scleroderma	0.000123	0.000458	CcSEcCtD
Amitriptyline—Rash—Methotrexate—systemic scleroderma	0.000122	0.000454	CcSEcCtD
Amitriptyline—Dermatitis—Methotrexate—systemic scleroderma	0.000122	0.000454	CcSEcCtD
Amitriptyline—Headache—Methotrexate—systemic scleroderma	0.000121	0.000451	CcSEcCtD
Amitriptyline—Nausea—Methotrexate—systemic scleroderma	0.000115	0.000428	CcSEcCtD
Amitriptyline—CHRM2—GPCR ligand binding—CCL2—systemic scleroderma	8.23e-06	0.000632	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	8.22e-06	0.00063	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR ligand binding—CCL2—systemic scleroderma	8.21e-06	0.00063	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—HSPG2—systemic scleroderma	8.15e-06	0.000625	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—RHOB—systemic scleroderma	8.03e-06	0.000616	CbGpPWpGaD
Amitriptyline—HTR1A—GPCR downstream signaling—EDN1—systemic scleroderma	8.03e-06	0.000616	CbGpPWpGaD
Amitriptyline—HTR2C—GPCR downstream signaling—EDN1—systemic scleroderma	7.98e-06	0.000613	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—HSPG2—systemic scleroderma	7.95e-06	0.00061	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—HSPG2—systemic scleroderma	7.91e-06	0.000607	CbGpPWpGaD
Amitriptyline—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	7.8e-06	0.000599	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling by GPCR—CCL2—systemic scleroderma	7.79e-06	0.000598	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CSK—systemic scleroderma	7.68e-06	0.000589	CbGpPWpGaD
Amitriptyline—ADRA1B—GPCR downstream signaling—EDN1—systemic scleroderma	7.64e-06	0.000586	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CSK—systemic scleroderma	7.64e-06	0.000586	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR ligand binding—CCL2—systemic scleroderma	7.63e-06	0.000585	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—EDN1—systemic scleroderma	7.58e-06	0.000582	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—HSPG2—systemic scleroderma	7.57e-06	0.000581	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—HSPG2—systemic scleroderma	7.47e-06	0.000574	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—RHOB—systemic scleroderma	7.4e-06	0.000568	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CSK—systemic scleroderma	7.31e-06	0.000561	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—EDN1—systemic scleroderma	7.29e-06	0.000559	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—RHOB—systemic scleroderma	7.28e-06	0.000559	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—RHOB—systemic scleroderma	7.27e-06	0.000558	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—EDN1—systemic scleroderma	7.25e-06	0.000556	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—RHOB—systemic scleroderma	7.25e-06	0.000556	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—RHOB—systemic scleroderma	7.22e-06	0.000554	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—RHOB—systemic scleroderma	7.15e-06	0.000549	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—RHOB—systemic scleroderma	7.13e-06	0.000547	CbGpPWpGaD
Amitriptyline—DRD2—GPCR downstream signaling—EDN1—systemic scleroderma	7.05e-06	0.000541	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	7.02e-06	0.000539	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—HSPG2—systemic scleroderma	7.01e-06	0.000538	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HSPG2—systemic scleroderma	6.98e-06	0.000536	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—EDN1—systemic scleroderma	6.94e-06	0.000533	CbGpPWpGaD
Amitriptyline—HTR2A—GPCR downstream signaling—EDN1—systemic scleroderma	6.93e-06	0.000532	CbGpPWpGaD
Amitriptyline—HRH1—GPCR downstream signaling—EDN1—systemic scleroderma	6.92e-06	0.000531	CbGpPWpGaD
Amitriptyline—CHRM1—GPCR downstream signaling—EDN1—systemic scleroderma	6.9e-06	0.000529	CbGpPWpGaD
Amitriptyline—CHRM3—GPCR downstream signaling—EDN1—systemic scleroderma	6.87e-06	0.000527	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—HSPG2—systemic scleroderma	6.87e-06	0.000527	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—HSPG2—systemic scleroderma	6.86e-06	0.000527	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HSPG2—systemic scleroderma	6.85e-06	0.000526	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—HSPG2—systemic scleroderma	6.85e-06	0.000526	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HSPG2—systemic scleroderma	6.83e-06	0.000524	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—CCL2—systemic scleroderma	6.83e-06	0.000524	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HSPG2—systemic scleroderma	6.81e-06	0.000523	CbGpPWpGaD
Amitriptyline—CHRM2—GPCR downstream signaling—EDN1—systemic scleroderma	6.81e-06	0.000522	CbGpPWpGaD
Amitriptyline—ADRA1A—GPCR downstream signaling—EDN1—systemic scleroderma	6.79e-06	0.000521	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HSPG2—systemic scleroderma	6.74e-06	0.000518	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CSK—systemic scleroderma	6.74e-06	0.000517	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—CCL2—systemic scleroderma	6.73e-06	0.000516	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—EDN1—systemic scleroderma	6.73e-06	0.000516	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HSPG2—systemic scleroderma	6.73e-06	0.000516	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—CCL2—systemic scleroderma	6.72e-06	0.000516	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—CCL2—systemic scleroderma	6.69e-06	0.000513	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—CCL2—systemic scleroderma	6.68e-06	0.000513	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CSK—systemic scleroderma	6.63e-06	0.000509	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—RHOB—systemic scleroderma	6.63e-06	0.000509	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—MMP1—systemic scleroderma	6.62e-06	0.000508	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CSK—systemic scleroderma	6.62e-06	0.000508	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CSK—systemic scleroderma	6.6e-06	0.000506	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CSK—systemic scleroderma	6.58e-06	0.000505	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—CCL2—systemic scleroderma	6.54e-06	0.000502	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CSK—systemic scleroderma	6.51e-06	0.0005	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CSK—systemic scleroderma	6.5e-06	0.000498	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—EDN1—systemic scleroderma	6.4e-06	0.000491	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—CCL2—systemic scleroderma	6.35e-06	0.000487	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—EDN1—systemic scleroderma	6.31e-06	0.000484	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—EDN1—systemic scleroderma	6.3e-06	0.000483	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—EDN1—systemic scleroderma	6.28e-06	0.000482	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—EDN1—systemic scleroderma	6.26e-06	0.000481	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HSPG2—systemic scleroderma	6.25e-06	0.00048	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—EDN1—systemic scleroderma	6.24e-06	0.000479	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—EDN1—systemic scleroderma	6.18e-06	0.000474	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—CTGF—systemic scleroderma	6.17e-06	0.000474	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—EDN1—systemic scleroderma	6.16e-06	0.000473	CbGpPWpGaD
Amitriptyline—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	6.16e-06	0.000472	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—CCL2—systemic scleroderma	6.09e-06	0.000467	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—NOS3—systemic scleroderma	6.08e-06	0.000467	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—CCL2—systemic scleroderma	6.08e-06	0.000467	CbGpPWpGaD
Amitriptyline—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic scleroderma	6.06e-06	0.000465	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CSK—systemic scleroderma	6.04e-06	0.000463	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—NOS3—systemic scleroderma	5.96e-06	0.000457	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—HSPG2—systemic scleroderma	5.93e-06	0.000455	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—EDN1—systemic scleroderma	5.9e-06	0.000453	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—HSPG2—systemic scleroderma	5.9e-06	0.000453	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—EDN1—systemic scleroderma	5.82e-06	0.000446	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—EDN1—systemic scleroderma	5.81e-06	0.000446	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—EDN1—systemic scleroderma	5.77e-06	0.000443	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—CCL2—systemic scleroderma	5.77e-06	0.000443	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—EDN1—systemic scleroderma	5.73e-06	0.00044	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—CCL2—systemic scleroderma	5.72e-06	0.000439	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—CCL2—systemic scleroderma	5.72e-06	0.000439	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—CTGF—systemic scleroderma	5.66e-06	0.000435	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—EDN1—systemic scleroderma	5.65e-06	0.000434	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—EDN1—systemic scleroderma	5.49e-06	0.000421	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—NOS3—systemic scleroderma	5.43e-06	0.000417	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—CTGF—systemic scleroderma	5.31e-06	0.000408	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—HSPG2—systemic scleroderma	5.3e-06	0.000406	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—EDN1—systemic scleroderma	5.25e-06	0.000403	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—CTGF—systemic scleroderma	5.2e-06	0.000399	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—CTGF—systemic scleroderma	5.19e-06	0.000398	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—CCL2—systemic scleroderma	5.18e-06	0.000398	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—HSPG2—systemic scleroderma	5.17e-06	0.000397	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—EDN1—systemic scleroderma	4.99e-06	0.000383	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—CCL2—systemic scleroderma	4.98e-06	0.000382	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—CCL2—systemic scleroderma	4.96e-06	0.00038	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—EDN1—systemic scleroderma	4.94e-06	0.000379	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—EDN1—systemic scleroderma	4.94e-06	0.000379	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—HSPG2—systemic scleroderma	4.87e-06	0.000374	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—HSPG2—systemic scleroderma	4.83e-06	0.00037	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—NOS3—systemic scleroderma	4.8e-06	0.000368	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—MMP9—systemic scleroderma	4.78e-06	0.000367	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—CCL2—systemic scleroderma	4.74e-06	0.000364	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—NOS3—systemic scleroderma	4.62e-06	0.000355	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—CCL2—systemic scleroderma	4.6e-06	0.000353	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—CTGF—systemic scleroderma	4.5e-06	0.000345	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—CTGF—systemic scleroderma	4.47e-06	0.000343	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—CCL2—systemic scleroderma	4.37e-06	0.000336	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—MMP9—systemic scleroderma	4.35e-06	0.000334	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EDN1—systemic scleroderma	4.31e-06	0.00033	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—CCL2—systemic scleroderma	4.3e-06	0.00033	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—CCL2—systemic scleroderma	4.29e-06	0.00033	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EDN1—systemic scleroderma	4.28e-06	0.000329	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—CCL2—systemic scleroderma	4.28e-06	0.000328	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—CCL2—systemic scleroderma	4.27e-06	0.000327	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—CCL2—systemic scleroderma	4.23e-06	0.000324	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—CCL2—systemic scleroderma	4.21e-06	0.000323	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—HSPG2—systemic scleroderma	4.13e-06	0.000317	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—NOS3—systemic scleroderma	4.1e-06	0.000315	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EDN1—systemic scleroderma	4.1e-06	0.000315	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CCL2—systemic scleroderma	4.03e-06	0.00031	CbGpPWpGaD
Amitriptyline—ADRA2A—Hemostasis—TGFB1—systemic scleroderma	4.02e-06	0.000309	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CTGF—systemic scleroderma	4.01e-06	0.000308	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CCL2—systemic scleroderma	3.98e-06	0.000305	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CCL2—systemic scleroderma	3.97e-06	0.000305	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CCL2—systemic scleroderma	3.95e-06	0.000303	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—TGFB1—systemic scleroderma	3.94e-06	0.000302	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CTGF—systemic scleroderma	3.92e-06	0.000301	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—CCL2—systemic scleroderma	3.92e-06	0.0003	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CCL2—systemic scleroderma	3.86e-06	0.000296	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EDN1—systemic scleroderma	3.78e-06	0.00029	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CCL2—systemic scleroderma	3.75e-06	0.000288	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EDN1—systemic scleroderma	3.72e-06	0.000285	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EDN1—systemic scleroderma	3.71e-06	0.000285	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—MMP9—systemic scleroderma	3.71e-06	0.000284	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EDN1—systemic scleroderma	3.7e-06	0.000284	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CTGF—systemic scleroderma	3.69e-06	0.000283	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EDN1—systemic scleroderma	3.69e-06	0.000283	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CTGF—systemic scleroderma	3.66e-06	0.000281	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EDN1—systemic scleroderma	3.65e-06	0.00028	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EDN1—systemic scleroderma	3.64e-06	0.000279	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—NOS3—systemic scleroderma	3.6e-06	0.000276	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CCL2—systemic scleroderma	3.59e-06	0.000276	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—TGFB1—systemic scleroderma	3.59e-06	0.000275	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—NOS3—systemic scleroderma	3.54e-06	0.000272	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—NOS3—systemic scleroderma	3.54e-06	0.000272	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—NOS3—systemic scleroderma	3.52e-06	0.00027	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—NOS3—systemic scleroderma	3.44e-06	0.000264	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CCL2—systemic scleroderma	3.41e-06	0.000262	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EDN1—systemic scleroderma	3.38e-06	0.00026	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CCL2—systemic scleroderma	3.38e-06	0.000259	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CCL2—systemic scleroderma	3.38e-06	0.000259	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—NOS3—systemic scleroderma	3.34e-06	0.000257	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MMP9—systemic scleroderma	3.29e-06	0.000252	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—NOS3—systemic scleroderma	3.2e-06	0.000246	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—HSPG2—systemic scleroderma	3.18e-06	0.000244	CbGpPWpGaD
Amitriptyline—ALB—Hemostasis—TGFB1—systemic scleroderma	3.17e-06	0.000244	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CTGF—systemic scleroderma	3.13e-06	0.00024	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—TGFB1—systemic scleroderma	3.06e-06	0.000234	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—NOS3—systemic scleroderma	3.04e-06	0.000233	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—NOS3—systemic scleroderma	3.01e-06	0.000231	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—NOS3—systemic scleroderma	3.01e-06	0.000231	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CCL2—systemic scleroderma	2.94e-06	0.000226	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CCL2—systemic scleroderma	2.93e-06	0.000225	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MMP9—systemic scleroderma	2.88e-06	0.000221	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MMP9—systemic scleroderma	2.84e-06	0.000218	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MMP9—systemic scleroderma	2.84e-06	0.000218	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MMP9—systemic scleroderma	2.82e-06	0.000217	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CCL2—systemic scleroderma	2.8e-06	0.000215	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MMP9—systemic scleroderma	2.76e-06	0.000212	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—TGFB1—systemic scleroderma	2.71e-06	0.000208	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—NOS3—systemic scleroderma	2.69e-06	0.000206	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MMP9—systemic scleroderma	2.68e-06	0.000206	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—NOS3—systemic scleroderma	2.62e-06	0.000201	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—NOS3—systemic scleroderma	2.61e-06	0.0002	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CCL2—systemic scleroderma	2.58e-06	0.000198	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MMP9—systemic scleroderma	2.57e-06	0.000197	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CCL2—systemic scleroderma	2.54e-06	0.000195	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CCL2—systemic scleroderma	2.54e-06	0.000195	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CCL2—systemic scleroderma	2.53e-06	0.000194	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CCL2—systemic scleroderma	2.52e-06	0.000193	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—NOS3—systemic scleroderma	2.5e-06	0.000192	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CCL2—systemic scleroderma	2.5e-06	0.000192	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CCL2—systemic scleroderma	2.49e-06	0.000191	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—NOS3—systemic scleroderma	2.47e-06	0.000189	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MMP9—systemic scleroderma	2.44e-06	0.000187	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MMP9—systemic scleroderma	2.41e-06	0.000185	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MMP9—systemic scleroderma	2.41e-06	0.000185	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CTGF—systemic scleroderma	2.41e-06	0.000185	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—TGFB1—systemic scleroderma	2.38e-06	0.000182	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—TGFB1—systemic scleroderma	2.34e-06	0.00018	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—TGFB1—systemic scleroderma	2.34e-06	0.00018	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—TGFB1—systemic scleroderma	2.33e-06	0.000178	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCL2—systemic scleroderma	2.31e-06	0.000177	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—NOS3—systemic scleroderma	2.31e-06	0.000177	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NOS3—systemic scleroderma	2.3e-06	0.000177	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—TGFB1—systemic scleroderma	2.28e-06	0.000175	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NOS3—systemic scleroderma	2.27e-06	0.000174	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—NOS3—systemic scleroderma	2.26e-06	0.000174	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NOS3—systemic scleroderma	2.26e-06	0.000174	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—NOS3—systemic scleroderma	2.26e-06	0.000173	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NOS3—systemic scleroderma	2.25e-06	0.000173	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NOS3—systemic scleroderma	2.25e-06	0.000172	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NOS3—systemic scleroderma	2.22e-06	0.000171	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NOS3—systemic scleroderma	2.22e-06	0.00017	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—TGFB1—systemic scleroderma	2.21e-06	0.00017	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TGFB1—systemic scleroderma	2.12e-06	0.000162	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MMP9—systemic scleroderma	2.1e-06	0.000161	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MMP9—systemic scleroderma	2.09e-06	0.000161	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NOS3—systemic scleroderma	2.06e-06	0.000158	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TGFB1—systemic scleroderma	2.01e-06	0.000154	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MMP9—systemic scleroderma	2e-06	0.000154	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TGFB1—systemic scleroderma	1.99e-06	0.000153	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TGFB1—systemic scleroderma	1.99e-06	0.000153	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—NOS3—systemic scleroderma	1.96e-06	0.00015	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—NOS3—systemic scleroderma	1.95e-06	0.000149	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MMP9—systemic scleroderma	1.85e-06	0.000142	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MMP9—systemic scleroderma	1.82e-06	0.00014	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MMP9—systemic scleroderma	1.81e-06	0.000139	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MMP9—systemic scleroderma	1.81e-06	0.000139	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MMP9—systemic scleroderma	1.8e-06	0.000138	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MMP9—systemic scleroderma	1.79e-06	0.000137	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MMP9—systemic scleroderma	1.78e-06	0.000137	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—NOS3—systemic scleroderma	1.75e-06	0.000134	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TGFB1—systemic scleroderma	1.73e-06	0.000133	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TGFB1—systemic scleroderma	1.73e-06	0.000132	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—NOS3—systemic scleroderma	1.7e-06	0.000131	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—systemic scleroderma	1.65e-06	0.000127	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TGFB1—systemic scleroderma	1.65e-06	0.000127	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—NOS3—systemic scleroderma	1.61e-06	0.000123	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—NOS3—systemic scleroderma	1.59e-06	0.000122	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFB1—systemic scleroderma	1.52e-06	0.000117	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFB1—systemic scleroderma	1.5e-06	0.000115	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFB1—systemic scleroderma	1.5e-06	0.000115	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFB1—systemic scleroderma	1.49e-06	0.000114	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFB1—systemic scleroderma	1.49e-06	0.000114	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFB1—systemic scleroderma	1.47e-06	0.000113	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFB1—systemic scleroderma	1.47e-06	0.000113	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFB1—systemic scleroderma	1.36e-06	0.000105	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—NOS3—systemic scleroderma	1.36e-06	0.000104	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NOS3—systemic scleroderma	1.05e-06	8.06e-05	CbGpPWpGaD
